These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8613352)

  • 1. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.
    Moses AE; Wessels MR; Zalcman K; Albertí S; Natanson-Yaron S; Menes T; Hanski E
    Infect Immun; 1997 Jan; 65(1):64-71. PubMed ID: 8975893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.
    Whitnack E; Beachey EH
    J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
    Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci.
    Wessels MR; Goldberg JB; Moses AE; DiCesare TJ
    Infect Immun; 1994 Feb; 62(2):433-41. PubMed ID: 8300204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M proteins of group G streptococci: mechanisms of resistance to phagocytosis.
    Campo RE; Schultz DR; Bisno AL
    J Infect Dis; 1995 Mar; 171(3):601-6. PubMed ID: 7876607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
    Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
    J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.
    Wessels MR; Bronze MS
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12238-42. PubMed ID: 7991612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci.
    Liu S; Courtney HS; Bessen DE; Hasty DL; Dale JB
    Adv Exp Med Biol; 1997; 418():725-7. PubMed ID: 9331754
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
    Pandiripally V; Gregory E; Cue D
    Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
    Marques MB; Kasper DL; Pangburn MK; Wessels MR
    Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spa contributes to the virulence of type 18 group A streptococci.
    McLellan DG; Chiang EY; Courtney HS; Hasty DL; Wei SC; Hu MC; Walls MA; Bloom JJ; Dale JB
    Infect Immun; 2001 May; 69(5):2943-9. PubMed ID: 11292710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
    McArthur JD; Walker MJ
    Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
    Whitnack E; Dale JB; Beachey EH
    J Exp Med; 1984 Apr; 159(4):1201-12. PubMed ID: 6368736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
    Schmidt KH; Wiesner J; Gerlach D; Reichardt W; Ozegowski JH; Köhler W
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):231-40. PubMed ID: 8275054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci.
    Lam C; Basalka E
    Eur J Clin Microbiol; 1985 Jun; 4(3):279-81. PubMed ID: 3894016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.